8-KEarnings & ResultsExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Financial Results (Jul 28, 2016)

Filed July 28, 2016For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) filed an 8-K on July 28, 2016, reporting its financial results for the second quarter of 2016. The filing primarily incorporates by reference a press release announcing these results and supplemental information available on the company's website. Investors should refer to the furnished press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) for detailed financial performance and operational updates for the quarter ending July 27, 2016. While this 8-K itself does not contain the specific financial figures, it serves as the official notification that BMY has released its Q2 2016 earnings. The attached press release and supplemental materials are expected to provide key metrics such as revenue, earnings per share (EPS), and insights into the company's product performance and future outlook. Investors are encouraged to review these exhibits for a comprehensive understanding of the company's second-quarter performance.

Key Highlights

  • 1BMY announced its second quarter 2016 financial results on July 28, 2016.
  • 2The 8-K filing incorporates a press release detailing Q2 2016 financial results.
  • 3Supplemental information regarding Q2 2016 performance is also furnished and available on the company's website.
  • 4Investors need to consult the attached exhibits (Press Release and Supplemental Information) for specific financial data.
  • 5The filing is dated July 27, 2016, reflecting the event date of the financial results announcement.
  • 6This report serves as official notification of BMY's Q2 2016 earnings release.

Frequently Asked Questions

This 8-K filing does not contain the specific financial figures for Q2 2016. Investors should refer to Exhibit 99.1 (the press release) and Exhibit 99.2 (supplemental information) furnished with this report for detailed results, including revenue, earnings per share, and other key performance indicators.

The detailed financial performance for Bristol-Myers Squibb's second quarter of 2016 can be found in the press release (Exhibit 99.1) and the supplemental information (Exhibit 99.2) which are incorporated by reference in this 8-K filing. This information is also available on the company's website at www.bms.com.

This 8-K filing is significant as it officially announces and provides access to Bristol-Myers Squibb's second quarter 2016 financial results. It directs investors to the primary sources of information, the press release and supplemental data, for a comprehensive understanding of the company's performance during the quarter.